Free Trial

Kymera Therapeutics (KYMR) Earnings Date, Estimates & Call Transcripts

$35.70
+0.38 (+1.08%)
(As of 04:00 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 2)
-$0.69 Beat By $0.04
Consensus EPS
(May. 2)
-$0.73
Skip Charts & View Estimated and Actual Earnings Data

KYMR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KYMR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Kymera Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244($0.83)($0.57)($0.75)
Q2 20244($0.86)($0.41)($0.70)
Q3 20244($0.88)($0.73)($0.80)
Q4 20244($0.85)($0.17)($0.67)
FY 202416($3.42)($1.88)($2.92)

KYMR Earnings Date and Information

Kymera Therapeutics last posted its earnings data on May 2nd, 2024. The reported ($0.69) EPS for the quarter, topping analysts' consensus estimates of ($0.73) by $0.04. The company earned $10.30 million during the quarter, compared to the consensus estimate of $14.24 million. Its quarterly revenue was up 8.4% compared to the same quarter last year. Kymera Therapeutics has generated ($2.51) earnings per share over the last year (($2.51) diluted earnings per share). Earnings for Kymera Therapeutics are expected to decrease in the coming year, from ($2.86) to ($3.15) per share. Kymera Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Kymera Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/2/2024Q1 2024($0.73)($0.69)+$0.04($0.69)$14.24 million$10.30 million    
2/22/2024Q4 2023($0.44)($0.25)+$0.19($0.25)$41.94 million$47.90 million    
11/2/2023Q3 2023($0.73)($0.90)($0.17)($0.90)$14.53 million$4.73 million
8/3/2023Q2 2023($0.70)($0.67)+$0.03($0.67)$13.93 million$16.51 million  
5/4/2023Q1 2023($0.69)($0.70)($0.01)($0.70)$14.15 million$9.47 million  
2/23/2023Q4 2022($0.57)($0.60)($0.03)($0.60)$20.66 million$16.10 million    
11/3/2022Q3 2022($0.70)($0.79)($0.09)($0.79)$16.42 million$9.55 million
8/9/2022Q2 2022($0.68)($0.78)($0.10)($0.78)$14.97 million$11.51 million    
5/3/2022Q1 2022($0.67)($0.71)($0.04)($0.71)$18.66 million$9.62 million    
2/24/2022Q4 2021($0.36)($0.66)($0.30)($0.66)$21.31 million$15.30 million    
11/10/2021Q3 2021($0.37)($0.56)($0.19)($0.56)$20.18 million$20.34 million
8/6/2021Q2 2021($0.25)($0.55)($0.30)($0.55)$18.81 million$18.50 million
5/6/2021Q1 2021($0.20)($0.29)($0.09)($0.29)$21.13 million$18.70 million  
3/11/2021Q4 2020($0.14)($0.29)($0.15)($0.29)$21.60 million$12.80 million
11/5/2020Q3 2020$0.72($0.39)($1.11)($0.39)-$14.53 million  

Kymera Therapeutics Earnings - Frequently Asked Questions

When is Kymera Therapeutics's earnings date?

Kymera Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on KYMR's earnings history.

Did Kymera Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Kymera Therapeutics (NASDAQ:KYMR) reported ($0.69) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.73) by $0.04. Learn more on analysts' earnings estimate vs. KYMR's actual earnings.

How can I listen to Kymera Therapeutics's earnings conference call?

The conference call for Kymera Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Kymera Therapeutics's conference call transcript?

The conference call transcript for Kymera Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Kymera Therapeutics generate each year?

Kymera Therapeutics (NASDAQ:KYMR) has a recorded annual revenue of $78.59 million.

How much profit does Kymera Therapeutics generate each year?

Kymera Therapeutics (NASDAQ:KYMR) has a recorded net income of -$146.96 million. KYMR has generated -$2.51 earnings per share over the last four quarters.

What is Kymera Therapeutics's EPS forecast for next year?

Kymera Therapeutics's earnings are expected to decrease from ($2.86) per share to ($3.15) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:KYMR) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners